Most recent
Early Heart Data Look Good for Obesity Drug
Interim data from a cardiovascular safety study of an investigational weight-loss agent have met FDA criteria, and drugmaker Orexigen Therapeutics will seek to resubmit the drug for U.S. approval. A company press…
3 min read